Cellular Origins and Lineage Plasticity in Cancer
Cold Spring Harbor Perspectives in Medicine · 2024-06 · 14 (6) · a041389
DOI: 10.1101/cshperspect.a041389 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cold Spring Harbor Perspectives in Medicine, online erschienen am 21.08.2023. Verfasst von Jason R Pitarresi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology and Oncology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01655, USA. Hauptthemen laut MEDLINE: Neoplasms, Cell Lineage. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 172 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Hematology and Oncology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01655, USA.
- Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Chan Medical School, Worcester, Massachusetts 01655, USA.
- Division of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA bstanger@upenn.edu.
ORCID-Profile: Ben Z Stanger
Förderung
- NCI NIH HHS
Zitieren
APA
Pitarresi, J. R., & Stanger, B. Z. (2024). Cellular Origins and Lineage Plasticity in Cancer. Cold Spring Harbor Perspectives in Medicine, 14(6), a041389. https://doi.org/10.1101/cshperspect.a041389
Vancouver
Pitarresi JR, Stanger BZ. Cellular Origins and Lineage Plasticity in Cancer. Cold Spring Harbor Perspectives in Medicine. 2024;14(6):a041389. doi:10.1101/cshperspect.a041389
BibTeX
@article{Pitarresi2024,
author = {Pitarresi, Jason R and Stanger, Ben Z},
title = {Cellular Origins and Lineage Plasticity in Cancer},
journal = {Cold Spring Harbor Perspectives in Medicine},
year = {2024},
volume = {14},
number = {6},
pages = {a041389},
doi = {10.1101/cshperspect.a041389}
}
EUVIMED